Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||
net income | 91,114,000 | 51,219,000 | 31,819,000 | 24,713,000 | -7,593,000 | -7,546,000 | -92,995,000 |
adjustments to reconcile net income to net cash from operating activities | |||||||
stock-based compensation | 40,739,000 | 35,474,000 | 42,446,000 | 48,218,000 | 45,535,000 | 43,067,000 | 97,768,000 |
depreciation and amortization | 1,466,000 | 1,392,000 | 1,125,000 | ||||
non-cash operating lease expense | 768,000 | 826,000 | 696,000 | 741,000 | 581,000 | 584,000 | 522,000 |
warrants contra revenue | 1,880,000 | 1,762,000 | 374,000 | 449,000 | 503,000 | 333,000 | 110,000 |
accretion of discounts on marketable securities | -1,789,000 | -1,947,000 | -2,542,000 | -3,231,000 | -1,071,000 | -566,000 | |
other | -503,000 | 1,759,000 | -1,025,000 | ||||
changes in operating assets and liabilities: | |||||||
accounts receivable | -18,580,000 | 45,459,000 | -30,968,000 | -13,426,000 | -3,156,000 | -5,476,000 | -8,422,000 |
inventory | 7,471,000 | -7,790,000 | -6,787,000 | -18,016,000 | 4,699,000 | -70,000 | -5,900,000 |
prepaid expenses and other assets | -38,286,000 | -3,979,000 | -14,495,000 | -8,033,000 | 398,000 | -2,730,000 | -2,666,000 |
accounts payable | -5,695,000 | 2,381,000 | 2,226,000 | 9,164,000 | 5,892,000 | 858,000 | 4,973,000 |
accrued expenses and other liabilities | 968,000 | 10,084,000 | -11,676,000 | -76,000 | 20,164,000 | 706,000 | 10,224,000 |
operating lease liability | -1,382,000 | -1,274,000 | -689,000 | -749,000 | -591,000 | -624,000 | -438,000 |
net cash from operating activities | 78,171,000 | 135,366,000 | 10,504,000 | 39,703,000 | 63,508,000 | 29,813,000 | 3,652,000 |
capex | -12,293,000 | -2,023,000 | -4,539,000 | -15,448,000 | -16,697,000 | 1,324,000 | -3,424,000 |
free cash flows | 65,878,000 | 133,343,000 | 5,965,000 | 24,255,000 | 46,811,000 | 31,137,000 | 228,000 |
cash flows from investing activities | |||||||
purchases of property and equipment | -12,293,000 | -2,023,000 | -4,539,000 | -15,448,000 | -16,697,000 | 1,324,000 | -3,424,000 |
purchases of marketable securities | -259,750,000 | -213,861,000 | -190,821,000 | -205,654,000 | -379,165,000 | -322,448,000 | -23,308,000 |
sales and maturities of marketable securities | 171,498,000 | 152,191,000 | 191,420,000 | ||||
other investing activities | |||||||
net cash from investing activities | -101,045,000 | -63,693,000 | -3,940,000 | -91,427,000 | -359,419,000 | -302,471,000 | -4,251,000 |
cash flows from financing activities | |||||||
proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | 0 | 0 | 0 | 672,198,000 | |||
payment of deferred offering costs | 0 | 0 | -3,045,000 | -1,756,000 | |||
tax withholding related to net share settlements of restricted stock units | 0 | 0 | 0 | -20,111,000 | |||
proceeds from exercises of stock options, net of repurchases | 952,000 | 392,000 | 386,000 | 1,247,000 | |||
proceeds from employee stock purchase plan | 0 | ||||||
net cash from financing activities | 952,000 | 4,737,000 | 386,000 | 5,651,000 | 952,000 | -2,343,000 | 651,578,000 |
net increase in cash, cash equivalents, and restricted cash | -21,922,000 | 76,410,000 | 6,950,000 | ||||
cash, cash equivalents, and restricted cash | |||||||
beginning of the period | 0 | 0 | 80,044,000 | 0 | 0 | 45,098,000 | |
end of the period | -21,922,000 | 76,410,000 | 86,994,000 | -294,959,000 | -275,001,000 | 696,077,000 | |
supplemental disclosures of cash flow information: | |||||||
conversion of redeemable convertible preferred stock into common stock in connection with initial public offering | 0 | 0 | 0 | 255,127,000 | |||
purchases of property and equipment in accounts payable, accrued expenses and other current liabilities | |||||||
right-of-use assets obtained in exchange for lease obligations | 439,000 | 174,000 | 231,000 | ||||
property and equipment acquired through tenant improvement allowance | |||||||
deferred offering costs included in accounts payable and accrued expenses | 3,045,000 | ||||||
depreciation | 974,000 | 849,000 | 717,000 | 614,000 | |||
inventory write-downs | -783,000 | -542,000 | |||||
accretion of discounts on marketable securities and other | |||||||
changes in operating assets and liabilities | |||||||
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | |||||||
proceeds from exercises of stock options | |||||||
repurchase of common stock upon termination | |||||||
beginning of the year | |||||||
end of the year | |||||||
supplemental cash flow information: | |||||||
exchange of common stock to series d redeemable convertible preferred stock | |||||||
income taxes paid | |||||||
maturities of marketable securities | 15,803,000 | 11,411,000 | 9,365,000 | ||||
sales of marketable securities | 20,640,000 | 7,242,000 | 13,116,000 | ||||
net increase in cash and cash equivalents | -294,959,000 | -275,001,000 | 650,979,000 | ||||
cash and cash equivalents | |||||||
proceeds (payments) from exercises of stock options, net of repurchases | |||||||
noncash investing and financing activities | |||||||
purchases of property and equipment in accounts payable and accrued expenses | |||||||
inventory write-down | 428,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
